OA12.02 Comparison of co-immunization of DNA and protein in the same anatomical sites and in contralateral sites to identify mechanisms of protective immune responseOral Abstract SessionNovel vaccine and other prevention approaches
OA12.03 Tetravalent immunogen assembled from conserved regions of HIV-1 and delivered as mRNA demonstrates potent preclinical T cell immunogenicity and breadthOral Abstract SessionNovel vaccine and other prevention approaches
OA12.04LB A VSV-based HIV-1 vaccine provides protection in macaques against low dose cross-clade SHIVenv_SF162_P3 challengeOral Abstract SessionNovel vaccine and other prevention approaches
OA12.05 Improved in vitro expression and in vivo immunogenicity of a candidate MVA-vectored HIV-1 vaccine compared to SAAVI MVA-COral Abstract SessionNovel vaccine and other prevention approaches
OA15.01 Heterologous vaccination with DNA and two different poxvirus vectors, expressing HIV-1 envelope on the surface of Gag virus-like particles, elicit autologous Tier 2 neutralising antibodiesOral Abstract SessionNovel vaccine and other prevention approaches
OA15.02 In vitro and in vivo analyses of HIV-1 clade C Envelope trimers highlight optimal antigenic profiles of novel HIV-1 Env-based vaccine candidatesOral Abstract SessionNovel vaccine and other prevention approaches
OA15.03 Novel trimer-only (TO) producing HIV-1 envelope glycoprotein constructs for inducing broadly neutralizing antibody responses by genetic vaccinationOral Abstract SessionNovel vaccine and other prevention approaches
OA15.04 Structural basis of neutralizing antibodies targeting the CD4-binding site and fusion peptide elicited by immunization with heterologous HIV-1 Env in NHPOral Abstract SessionNovel vaccine and other prevention approaches
OA15.05LB Cross-reactivity between HIV-1 bnAbs and parasite glycansOral Abstract SessionNovel vaccine and other prevention approaches
OA18.05LB Multivalent antigen presentation increases the antibody binding breadth and neutralizing potency upon the immunization with a self-assembling HIV env vaccineOral Abstract SessionNovel vaccine and other prevention approaches
seek-warrow-warrow-eseek-e71 - 80 of 444 items